MSH2 and neoplasm: Four tumours had a single variant at low allele frequency (MSH2 c.2458+1G>A (5.04%), MSH2 c.1003dupA (9.5%), MSH6 c.3261delC (10.1%) and MSH6 c.718C>T (13.2%)), which precluded a sensitive LOH analysis.